Search results
The Best Products For Treating Psoriasis, According To Dermatologists
HuffPost· 5 days agoLa Roche-Posay triple repair body cream, CeraVe psoriasis cream and scalp psoriasis shampoo and...
Alumis sets out IPO ambitions to fund TYK2 inhibitor through phase 3 psoriasis trials
FierceBiotech· 7 days agoSpecifically, Alumis plans to use part of the IPO haul to advance the development of its lead asset,...
Tapinarof may mark Dermavant’s first atopic dermatitis approval
Clinical Trials Arena via Yahoo Finance· 5 days agoTapinarof is an aryl hydrocarbon receptor (AhR) receptor modulator that has been observed to have...
Northwest Wealth Management LLC Makes New $242,000 Investment in Amgen Inc. (NASDAQ:AMGN)
ETF DAILY NEWS· 5 days agoThe institutional investor bought 840 shares of the medical research company’s stock, valued at approximately $242,000. Several other institutional investors have also made changes to their positions in the stock.
Cantor Fitzgerald L. P. Invests $33,000 in Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT)
ETF DAILY NEWS· 4 days agoCantor Fitzgerald L. P. bought a new stake in Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT – Free Report) in the fourth quarter, Holdings Channel.com reports. The institutional investor bought ...
Lighthouse Investment Partners LLC Invests $272,000 in Biogen Inc. (NASDAQ:BIIB)
ETF DAILY NEWS· 5 days agoLighthouse Investment Partners LLC purchased a new position in shares of Biogen Inc. (NASDAQ:BIIB – Free Report) during the 4th quarter, according to the company in its most recent Form 13F ...
Putnam Investments LLC Raises Stock Holdings in Option Care Health, Inc. (NASDAQ:OPCH)
ETF DAILY NEWS· 5 days agoPutnam Investments LLC raised its position in shares of Option Care Health, Inc. (NASDAQ:OPCH – Free Report) by 8.0% in the 4th quarter, according to the company in its most recent Form 13F ...
Shell Asset Management Co. Sells 9,507 Shares of AbbVie Inc. (NYSE:ABBV)
ETF DAILY NEWS· 7 days agoShell Asset Management Co. cut its stake in shares of AbbVie Inc. (NYSE:ABBV – Free Report) by 19.4% during the 4th quarter, according to the company in its most recent 13F filing with the Securities ...
Biogen Inc. (NASDAQ:BIIB) Receives $286.50 Consensus Target Price from Analysts
ETF DAILY NEWS· 2 days agoShares of Biogen Inc. (NASDAQ:BIIB – Get Free Report) have been assigned a consensus recommendation of “Moderate Buy” from the twenty-six brokerages that are covering the firm, MarketBeat Ratings ...
Alvotech (NASDAQ:ALVO) Short Interest Update
ETF DAILY NEWS· 3 days agoAlvotech (NASDAQ:ALVO – Get Free Report) was the recipient of a significant drop in short interest in the month of May. As of May 31st, there was short interest totalling 93,900 shares, a drop ...